Navigation Links
Scientists ID First Human With Gorilla Strain of HIV
Date:8/2/2009

smitted through several people before reaching her.

It's not clear how long the strain has been in existence, but the research suggests that it has made it through several "rounds" of infection, Johnston said.

"The jury is still out as to whether this is bad news relative to strains of HIV that are already circulating," she said. "We just can't draw those kinds of conclusions from one person."

The woman's case is unusual, however, and that fact may be revealing, said Dr. Philip R. Johnson, an AIDS specialist and chief scientific officer at Children's Hospital of Philadelphia.

The level of virus in the woman's body is high but she doesn't appear to have symptoms, potentially suggesting that the strain isn't strong, he said.

In the big picture, it's possible that the disease didn't pass directly from gorillas to humans, but instead took another route, Johnson added.

"More cases will need to be found. The key is that [researchers] now have the tools to look [for them]," he said.

It's possible, he said, that scientists missed similar cases in the past because testing technology couldn't detect them.

More information

Find out more about HIV/AIDS at the U.S. Centers for Disease Control and Prevention.



SOURCES: Rowena Johnston, Ph.D., vice president, research, Foundation for AIDS Research, New York City; Philip R. Johnson, M.D., chief scientific officer, Children's Hospital of Philadelphia, and professor, pediatrics, University of Pennsylvania School of Medicine, Philadelphia; Aug. 2, 2009, Nature Medicine, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

5

GOOD

Page: 1 2

Related medicine news :

1. Scientists learn why even treated genital herpes sores boost the risk of HIV infection
2. UF scientists program blood stem cells to become vision cells
3. Scientists Find Way to Make Good Brown Fat
4. Scientists Test New Way to Get Drugs to Cancer Cells
5. Ethicon Endo-Surgery Holds Metabolic Surgery Scientific Forum Featuring Research By Top Scientists
6. Scientists Track Impact of DNA Damage in the Developing Brain
7. Scientists discover key event in prostate cancer progression
8. Scientists Use Non-Embryonic Stem Cells to Create Healthy Mice
9. Scientists Use Adult Stem Cells to Create Healthy Mice
10. Scientists locate disease switches
11. Scientists Reverse Muscular Dystrophy in Mice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists ID First Human With Gorilla Strain of HIV
Scientists ID First Human With Gorilla Strain of HIV
(Date:3/18/2010)... Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... ... WASHINGTON , March 18 Kids in New Jersey will take center stage in the fight against tobacco on March ...
(Date:3/18/2010)... ... , , ... ... ... New Hampshire will take center stage in the fight against tobacco on March 24 as they join thousands of young people nationwide ...
(Date:3/18/2010)... President and CEO, Legacy(SM) , ... , , ... ... WASHINGTON , March ... ...
(Date:3/18/2010)... of U.S. medical students choosing internal medicine residencies ... significantly impact the shortage of primary care physicians. ... Program report, 2,722 U.S. seniors at medical schools ... 3.4 percent increase from 2,632 in 2009. The ... (2,660), 2007 (2,680), and 2006 (2,668). In comparison, ...
(Date:3/18/2010)... In its 21-year history, under the ... leaders, SRLA has trained more than 40,000 teenagers from ... area to complete the 26.2 mile Los Angeles Marathon. ... volunteer leaders will again participate in the LA Marathon. ... SRLA,s mission is to challenge at-risk secondary students to ...
Breaking Medicine News(10 mins):Health News:New Jersey Kids 'Kick Butts' on March 24 2Health News:New Jersey Kids 'Kick Butts' on March 24 3Health News:New Jersey Kids 'Kick Butts' on March 24 4Health News:New Jersey Kids 'Kick Butts' on March 24 5Health News:New Hampshire Kids 'Kick Butts' on March 24 2Health News:New Hampshire Kids 'Kick Butts' on March 24 3Health News:New Hampshire Kids 'Kick Butts' on March 24 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5Health News:Residency match results not encouraging for adults needing primary care 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3
... and its not good. Worse, the patient has to ... risky. None of them promises complete success. How ... best treatment for their own healthcare? , These ... of Medical Decision Making (MDM) about the future of ...
... Units where critical care specialists manage patients fare better, study ... injury patients were about one-third less likely to die if ... required board-certified critical care doctors to oversee patient care, says ... an inflammatory disorder of the lung often seen in patients ...
... But Aricept may help stave off cognitive decline, researchers ... a drug commonly used to treat the cognitive symptoms ... when it comes to treating the agitation associated with ... with other research, the trial suggests that doctors and ...
... It cuts rates of hospitalizations and deaths, study finds, , , WEDNESDAY, ... an annual flu shot will reduce the risk you,ll be hospitalized ... flu-related death by 48 percent. , That,s the conclusion of new ... England Journal of Medicine . , "This is a bad disease ...
... and Override the Veto, WASHINGTON, Oct. 3 ... officer of the Catholic Health Association of,the United ... vetoing legislation to reauthorize the State Children,s Health,Insurance ... politics,with the lives of ten million children in ...
... The Missouri House of Representatives,recognized a TriWest ... state,s National Guard Service members and their,families. ... service and,education representative serving Missouri, in an award ... energy to assisting soldiers,and airmen of the Missouri ...
Other Medicine News:Health News:Type of ICU Influences Lung Injury Survival 2Health News:Alzheimer's Drug Won't Ease Patients' Agitation 2Health News:Alzheimer's Drug Won't Ease Patients' Agitation 3Health News:Alzheimer's Drug Won't Ease Patients' Agitation 4Health News:Flu Vaccine Does Protect Older People 2Health News:Flu Vaccine Does Protect Older People 3Health News:Missouri House Recognizes 'Extraordinary' Efforts Supporting National Guard Families 2
(Date:3/18/2010)... March 18 Poniard Pharmaceuticals, Inc. ... innovative oncology therapies, today announced that the U.S. Patent ... the composition of matter patent for picoplatin as RE41209, ... 2010 . The reissue was applied for May ... , the USPTO released the "Issue Notification" for the ...
(Date:3/18/2010)... , March 18 ... Chief Executive Officer, Pfizer, was elected board ... of America (PhRMA) today at the trade ... Chief Executive Officer Christopher Viehbacher ... Directors, and John C. Lechleiter , ...
(Date:3/18/2010)... results in too much ammonia in the blood. , ... , , ... ... (Logo: ... ...
Breaking Medicine Technology:U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 2U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 3U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 4U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 2FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 3FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 4FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 5Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 1Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 2Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 3Exposure to lead tobacco smoke raises risk of ADHD 10856 1Exposure to lead tobacco smoke raises risk of ADHD 10856 2Measuring and modeling blood flow in malaria 61892 1Measuring and modeling blood flow in malaria 61892 2
... Watson,Pharmaceuticals, Inc. (NYSE: WPI ), a leading ... Extended-Release,Tablets, USP in the 500 mg strength. Watson,s ... Biaxin(R),XL, which is indicated to treat or prevent ... caused by susceptible bacteria. For the 12-months,ending September ...
... Jan. 3 Takeda Pharmaceutical Company,Limited (Takeda) ... Development,Center, Inc. submitted a New Drug Application ... Administration (FDA) for alogliptin (development code:,SYR-322), a ... for the treatment of type 2 diabetes. ...
Other Medicine Technology:Watson Launches Generic Biaxin(R) XL 2Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 2Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 3Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: